The Phase III trial builds on findings from prior findings that indicated Anktiva can restore T-cell function and improve overall survival in patients with advanced of metastatic non-small cell lung ...
The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...
LEXINGTON, Mass. - Agenus Inc . (NASDAQ:AGEN), an immuno-oncology company with a market capitalization of $85 million, revealed study results published in the Journal of Clinical Oncology that ...